|
| 36710452 | Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes. | J Diabetes Sci Technol | 2024 |
| 36106652 | Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes. | Diabetes Obes Metab | 2023 |
| 35348391 | A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings. | J Diabetes Sci Technol | 2023 |
| 37056168 | Real-Time Continuous Glucose Monitoring in the Hospital: A Real-World Experience. | J Diabetes Sci Technol | 2023 |
| 37148899 | Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial. | Lancet Diabetes Endocrinol | 2023 |
| 37011033 | Process evaluation of Dulce Digital-Me: an adaptive mobile health (mHealth) intervention for underserved Hispanics with diabetes. | Transl Behav Med | 2023 |
| 36697929 | Mi Puente (My Bridge) Care Transitions Program for Hispanic/Latino Adults with Multimorbidity: Results of a Randomized Controlled Trial. | J Gen Intern Med | 2023 |
| 36472543 | Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial. | Diabetes Technol Ther | 2023 |
| 34605127 | Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial. | Diabetes Obes Metab | 2022 |
| 35090520 | Dulce Digital-Me: protocol for a randomized controlled trial of an adaptive mHealth intervention for underserved Hispanics with diabetes. | Trials | 2022 |
| 35294272 | Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes. | Diabetes Technol Ther | 2022 |
| 34791499 | Process evaluation of a medical assistant health coaching intervention for type 2 diabetes in diverse primary care settings. | Transl Behav Med | 2022 |
| 34694909 | Safety and Glycemic Outcomes During the MiniMedâ¿¢ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes. | Diabetes Technol Ther | 2022 |
| 33053431 | Medical assistant health coaching ("MAC") for type 2 diabetes in diverse primary care settings: A pragmatic, cluster-randomized controlled trial protocol. | Contemp Clin Trials | 2021 |
| 35265925 | Digital health tools to promote diabetes education and management of cardiovascular risk factors among under-resourced populations. | Cardiovasc Digit Health J | 2021 |
| 34400466 | 100 years on: the impact of the discovery of insulin on clinical outcomes. | BMJ Open Diabetes Res Care | 2021 |
| 32228288 | Does Diabetes Distress Influence Clinical Response to an mHealth Diabetes Self-Management Education and Support Intervention? | Diabetes Educ | 2020 |
| 31903697 | The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100â¿¿units/mL. | Diabetes Obes Metab | 2020 |
| 32051005 | My Bridge (Mi Puente), a care transitions intervention for Hispanics/Latinos with multimorbidity and behavioral health concerns: protocol for a randomized controlled trial. | Trials | 2020 |
| 31984443 | Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial. | Diabetologia | 2020 |
| 31858673 | Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase-4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trials. | Diabetes Obes Metab | 2020 |
| 31944895 | Care Team Integration in Primary Care Improves One-Year Clinical and Financial Outcomes in Diabetes: A Case for Value-Based Care. | Popul Health Manag | 2020 |
| 32996693 | Development of a hypoglycaemia risk score to identify high-risk individuals with advanced type 2 diabetes in DEVOTE. | Diabetes Obes Metab | 2020 |
| 32855160 | Glucose as the Fifth Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a Non-ICU Hospital Setting. | Diabetes Care | 2020 |
| 32250536 | Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE. | Diabetes Obes Metab | 2020 |
| 32543682 | Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. | JAMA | 2020 |
| 30362250 | Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials. | Diabetes Obes Metab | 2019 |
| 31871504 | Periodic Intensive Insulin Therapy Remains Experimental. | Curr Ther Res Clin Exp | 2019 |
| 31798285 | Innovative Diabetes Interventions in the U.S. Hispanic Population. | Diabetes Spectr | 2019 |
| 31798283 | Innovative Solutions to Care for Individuals With Diabetes in Underserved Populations. | Diabetes Spectr | 2019 |
| 30949906 | Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials. | Diabetes Ther | 2019 |
| 30705500 | Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial. | Clin Diabetes | 2019 |
| 30833170 | Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial. | Lancet Diabetes Endocrinol | 2019 |
| 30974986 | Efficacy and Safety of Degludec Compared to Glargine 300 Units/mL in Insulin-Experienced Patients With Type 2 Diabetes: Trial Protocol Amendment (NCT03078478). | J Diabetes Sci Technol | 2019 |
| 30761720 | Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes. | Diabetes Obes Metab | 2019 |
| 30600137 | Efficacy and tolerability of exenatide once weekly over 7⿯years in patients with type 2 diabetes: An open-label extension of the DURATION-1 study. | J Diabetes Complications | 2019 |
| 30448451 | Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus. | Diabetes Res Clin Pract | 2019 |
| 29316130 | Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial. | Diabetes Obes Metab | 2018 |
| 29720273 | When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation. | Health Qual Life Outcomes | 2018 |
| 28672316 | Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial. | JAMA | 2017 |
| 28282219 | A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges. | Diabetes Technol Ther | 2017 |
| 28356319 | Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1). | Diabetes Care | 2017 |
| 28209654 | REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes. | Diabetes Care | 2017 |
| 29749824 | Patient perspectives on whole-genome sequencing for undiagnosed diseases. | Per Med | 2017 |
| 29059040 | Pilot Test of a Culturally Appropriate Diabetes Prevention Intervention for At-Risk Latina Women. | Diabetes Educ | 2017 |
| 28600309 | Dulce Digital: An mHealth SMS-Based Intervention Improves Glycemic Control in Hispanics With Type 2 Diabetes. | Diabetes Care | 2017 |
| 26914371 | Dulce Wireless Tijuana: A Randomized Control Trial Evaluating the Impact of Project Dulce and Short-Term Mobile Technology on Glycemic Control in a Family Medicine Clinic in Northern Mexico. | Diabetes Technol Ther | 2016 |
| 27846338 | An Evolutionary Perspective on Basal Insulin in Diabetes Treatment: Innovations in Insulin: Insulin Degludec U-100 and U-200. | J Fam Pract | 2016 |
| 26990378 | Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study). | Diabetes Obes Metab | 2016 |
| 25539653 | Novel approach to inpatient glucometric monitoring and variability in a community hospital setting. | J Diabetes Sci Technol | 2015 |